Skip to main content
    M

    Medpace Holdings Inc (MEDP)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $648.20
    -5.74 (-0.88%)

    Market Cap: $18.29B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Medpace Holdings Inc (MEDP) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Medpace Holdings (MEDP) to earn $18.36 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.85B. Of 14 analysts, 2 rate the stock Buy or Strong Buy, 11 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 10 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 14 ratings average 2.86, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 14% of the ratings.

    RatingAnalystsShare
    Strong Buy17.1%
    Buy17.1%
    Hold1178.6%
    Sell17.1%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    14

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 8.1% and revenue estimates rise 6.0%.

    Fiscal year ending Dec 31, 2026
    $18.36
    EPS consensus, revenue $2.85B
    Fiscal year ending Dec 31, 2027
    $19.85
    EPS consensus, revenue $3.02B
    Next report
    Feb 8, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$18.36$18.11 to $18.9211$2.85B$2.84B to $2.86B13
    Dec 31, 2027$19.85$19.30 to $20.3511$3.02B$2.86B to $3.08B13

    Quarterly Estimates

    The EPS consensus falls from $4.93 for the quarter ending Dec 31, 2026 to $4.66 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$4.93$4.67 to $5.2014$732.76M$695.80M to $761.25M14
    Mar 31, 2027$4.66$4.50 to $4.917$726.89M$713.67M to $742.22M8

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 19 upward and 1 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 2026100
    Fiscal year ending Dec 31, 202791

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 3.7% from $17.70.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$18.36$17.72$17.70$17.70$17.70+3.7%
    Fiscal year ending Dec 31, 2027$19.85$19.32$19.31$19.31$19.31+2.8%
    Quarter ending Mar 31, 2027$4.66$4.59$4.61$4.61$4.61+1.0%

    Frequently Asked Questions About MEDP

    What is the MEDP stock forecast?

    Consensus analyst estimates put Medpace Holdings's EPS at $18.36 for the fiscal year ending Dec 31, 2026, on revenue of $2.85B. The consensus rating from 14 analysts is Hold.

    How do analysts rate MEDP stock?

    Of 14 analysts covering Medpace Holdings, 1 rates it Strong Buy, 1 Buy, 11 Hold, 1 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from MEDP next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $18.36, with estimates from $18.11 to $18.92 from 11 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $19.85, with estimates from $19.30 to $20.35 from 11 analysts.

    What revenue do analysts expect from Medpace Holdings next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.85B, with estimates from $2.84B to $2.86B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.02B, with estimates from $2.86B to $3.08B.

    How many analysts cover MEDP?

    14 analysts rate Medpace Holdings stock, and 11 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.